Friday December 15th 2017

Arsenicals May Prevent Axonal Loss in Multiple Sclerosis: A Histopathological Study (P1.209)

Conclusions: These data indicate that arsenicals may have exerted a neuroprotective effect in MS patients by preventing axonal degeneration. This neuroprotective potential of arsenicals in MS merits further investigation.Study supported by: Merck Serono, GreeceDisclosure: Dr. Papadopoulos has nothing to disclose. Dr. Antoniou has nothing to disclose. Dr. Tsimaratou has nothing to disclose. Dr. Gorgoulis has nothing to disclose. Dr. Mitsikostas has received personal compensation for activities with Allergan Inc., Janssen-Cilag, Bayer Schering, Eli Lilly & Co., Menarini, Merk Serono, Merck Sharp & Dohme Ltd., Novartis, Novis, Pfizer Inc. and UCB Pharma as a consultant. Dr. Mitsikostas has received personal compensation in an editorial capacity for Executive Board of European Headache…

Visit link – 

Arsenicals May Prevent Axonal Loss in Multiple Sclerosis: A Histopathological Study (P1.209)

Leave a Comment

More from category

Germany’s Merck to make new bid to enter U.S. MS pill market
Germany’s Merck to make new bid to enter U.S. MS pill market

FRANKFURT (Reuters) - Germany's Merck KGaA is reviving plans to bring an oral multiple sclerosis (MS) treatment to the [Read More]

Researchers develop new method for quickly detecting signs of multiple sclerosis
Researchers develop new method for quickly detecting signs of multiple sclerosis

A METHOD for quickly detecting signs of multiple sclerosis has been developed by a University of Huddersfield research [Read More]

Terror survivors have increased risk of frequent migraine, tension headaches
Terror survivors have increased risk of frequent migraine, tension headaches

Survivors of a terror attack have an increased risk of frequent migraine and tension headaches after the attack, [Read More]

Scientists discover blood sample detection method for multiple sclerosis
Scientists discover blood sample detection method for multiple sclerosis

(University of Huddersfield) Researchers identified two natural biomarker compounds present in the blood. (Source: [Read More]

Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s
Study: The medical community isn’t prepared for the looming pandemic of neurodegenerative diseases like Parkinson’s

(Natural News) Parkinson’s disease is the second most common neurodegenerative disease plaguing people today, with an [Read More]